Shree Pacetronix [SHREEPAC] vs Dr Agarwal's Health [AGARWALEYE] Detailed Stock Comparison
Shree Pacetronix
BSE
Loading...
Dr Agarwal's Health
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Shree Pacetronix wins in 13 metrics, Dr Agarwal's Health wins in 4 metrics, with 0 ties. Shree Pacetronix appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Shree Pacetronix | Dr Agarwal's Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 70.45 | 137.59 | Shree Pacetronix |
| Price-to-Book Ratio | 5.33 | 7.50 | Shree Pacetronix |
| Debt-to-Equity Ratio | 36.79 | 49.87 | Shree Pacetronix |
| PEG Ratio | 0.88 | N/A | N/A |
| EV/EBITDA | 28.70 | 35.60 | Shree Pacetronix |
| Profit Margin (TTM) | 6.03% | 5.66% | Shree Pacetronix |
| Operating Margin (TTM) | 18.43% | 13.32% | Shree Pacetronix |
| EBITDA Margin (TTM) | 18.43% | 13.32% | Shree Pacetronix |
| Return on Equity | 5.44% | 4.33% | Shree Pacetronix |
| Return on Assets (TTM) | 3.25% | 2.27% | Shree Pacetronix |
| Free Cash Flow (TTM) | $-7.25M | $394.30M | Dr Agarwal's Health |
| 1-Year Return | 31.76% | 9.20% | Shree Pacetronix |
| Price-to-Sales Ratio (TTM) | 4.24 | 7.80 | Shree Pacetronix |
| Enterprise Value | $770.67M | $146.19B | Dr Agarwal's Health |
| EV/Revenue Ratio | 4.46 | 8.15 | Shree Pacetronix |
| Gross Profit Margin (TTM) | 68.11% | 43.48% | Shree Pacetronix |
| Revenue per Share (TTM) | $48 | $58 | Dr Agarwal's Health |
| Earnings per Share (Diluted) | $2.89 | $3.22 | Dr Agarwal's Health |
| Beta (Stock Volatility) | -1.61 | N/A | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Shree Pacetronix vs Dr Agarwal's Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Shree Pacetronix | 1.98% | 10.34% | 41.45% | 160.52% | 214.57% | 67.17% |
| Dr Agarwal's Health | 1.14% | 2.85% | 0.79% | 11.15% | 5.44% | 9.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Shree Pacetronix | 31.76% | 258.98% | 1,580.95% | 869.34% | 473.21% | 961.65% |
| Dr Agarwal's Health | 9.20% | 9.20% | 9.20% | 9.20% | 9.20% | 9.20% |
News Based Sentiment: Shree Pacetronix vs Dr Agarwal's Health
Shree Pacetronix
News based Sentiment: MIXED
Shree Pacetronix is experiencing strong positive price momentum, with a 10-day winning streak and a significant cumulative gain since August 4th. However, underlying financial health concerns regarding cash flow and capital allocation, highlighted in earlier September analysis, create a mixed investment picture. The upcoming October 17th earnings report will be crucial in determining whether the company can address these concerns and sustain its recent gains.
Dr Agarwal's Health
News based Sentiment: MIXED
September saw continued movement on the key merger, but also initial market hesitation and the need for ongoing investor communication. While analyst confidence remains, the merger's success isn't guaranteed, making this a significant but complex month for investors.
Performance & Financial Health Analysis: Shree Pacetronix vs Dr Agarwal's Health
| Metric | SHREEPAC | AGARWALEYE |
|---|---|---|
| Market Information | ||
| Market Cap | ₹747.42M | ₹138.90B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 12,847 | 180,915 |
| 90 Day Avg. Volume | 17,079 | 271,375 |
| Last Close | ₹216.00 | ₹444.05 |
| 52 Week Range | ₹61.11 - ₹216.00 | ₹327.00 - ₹494.50 |
| % from 52W High | 0.00% | -10.20% |
| All-Time High | ₹391.90 (Nov 06, 2023) | ₹494.50 (Jul 30, 2025) |
| % from All-Time High | -44.88% | -10.20% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.21% |
| Quarterly Earnings Growth | 0.78% | 1.51% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.06% |
| Operating Margin (TTM) | 0.18% | 0.13% |
| Return on Equity (TTM) | 0.05% | 0.04% |
| Debt to Equity (MRQ) | 36.79 | 49.87 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹38.18 | ₹59.09 |
| Cash per Share (MRQ) | ₹3.22 | ₹16.23 |
| Operating Cash Flow (TTM) | ₹-2,503,000 | ₹1.43B |
| Levered Free Cash Flow (TTM) | ₹7.50M | ₹834.60M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Shree Pacetronix vs Dr Agarwal's Health
| Metric | SHREEPAC | AGARWALEYE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 70.45 | 137.59 |
| Forward P/E | N/A | 79.00 |
| PEG Ratio | 0.88 | N/A |
| Price to Sales (TTM) | 4.24 | 7.80 |
| Price to Book (MRQ) | 5.33 | 7.50 |
| Market Capitalization | ||
| Market Capitalization | ₹747.42M | ₹138.90B |
| Enterprise Value | ₹770.67M | ₹146.19B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.46 | 8.15 |
| Enterprise to EBITDA | 28.70 | 35.60 |
| Risk & Other Metrics | ||
| Beta | -1.61 | N/A |
| Book Value per Share (MRQ) | ₹38.18 | ₹59.09 |
Financial Statements Comparison: Shree Pacetronix vs Dr Agarwal's Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SHREEPAC | AGARWALEYE |
|---|---|---|
| Revenue/Sales | ₹53.43M | ₹4.87B |
| Cost of Goods Sold | ₹17.04M | ₹2.75B |
| Gross Profit | ₹36.39M | ₹2.12B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹9.85M | ₹649.10M |
| EBITDA | ₹11.81M | ₹1.41B |
| Pre-Tax Income | ₹8.90M | ₹536.00M |
| Income Tax | ₹2.26M | ₹155.40M |
| Net Income (Profit) | ₹6.65M | ₹380.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SHREEPAC | AGARWALEYE |
|---|---|---|
| Cash & Equivalents | ₹2.54M | ₹1.04B |
| Total Current Assets | ₹171.89M | ₹7.94B |
| Total Current Liabilities | ₹88.66M | ₹4.78B |
| Long-Term Debt | ₹3.61M | ₹8.08B |
| Total Shareholders Equity | ₹137.82M | ₹19.27B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹37.88M | ₹13.40B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SHREEPAC | AGARWALEYE |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SHREEPAC | AGARWALEYE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 12,847 | 180,915 |
| Average Daily Volume (90 Day) | 17,079 | 271,375 |
| Shares Outstanding | 3.60M | 315.88M |
| Float Shares | 1.26M | 53.12M |
| % Held by Insiders | 0.59% | 0.76% |
| % Held by Institutions | 0.00% | 0.17% |
Dividend Analysis & Yield Comparison: Shree Pacetronix vs Dr Agarwal's Health
| Metric | SHREEPAC | AGARWALEYE |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |